Acasă › Cancer ovarian › Virginia › Arlington
Studii clinice pentru Cancer ovarian în Arlington, VA
46 studii pentru Cancer ovarian caută participanți în și în jurul orașului Arlington (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
The Vanguard Study: Testing a New Way to Screen for Cancer
În curs de recrutareVoluntari sănătoși bineveniți
- Inova Schar Cancer Institute, Fairfax · La 11 mi distanță
- Inova Fair Oaks Hospital, Fairfax · La 11 mi distanță
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
În curs de recrutareFaza 2
- Inova Fairfax Hospital, Falls Church · La 4 mi distanță
- Inova Schar Cancer Institute, Fairfax · La 11 mi distanță
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
În curs de recrutareFaza 1/2
- Research Site, Fairfax · La 11 mi distanță
A Study of PHST001 in Advanced Solid Tumors
În curs de recrutareFaza 1
- NEXT Oncology - Virginia, Fairfax · La 11 mi distanță
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 1
- Inova Schar Cancer Institute, Fairfax · La 11 mi distanță
- NEXT Virginia, Fairfax · La 11 mi distanță
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
În curs de recrutareFaza 1/2
- Virginia Cancer Specialists, Fairfax · La 11 mi distanță
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
În curs de recrutareFaza 1
- NEXT Virginia, Fairfax · La 11 mi distanță
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
În curs de recrutareFaza 2
- Next Virginia /ID# 279684, Fairfax · La 11 mi distanță
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
În curs de recrutareFaza 1
- Site 04, Fairfax · La 11 mi distanță
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
În curs de recrutareFaza 1
- Next Virginia /ID# 278607, Fairfax · La 11 mi distanță
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
În curs de recrutareFaza 1/2
- NEXT Virginia, Fairfax · La 11 mi distanță
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
În curs de recrutareFaza 2
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 276456, Fairfax · La 11 mi distanță
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
În curs de recrutareFaza 2
- Site 0322 - Inova Schar Cancer Institute, Fairfax · La 11 mi distanță
Study of AVZO-021 in Patients With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · La 11 mi distanță
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
În curs de recrutareFaza 1/2
- NEXT Oncology Virginia, Fairfax · La 11 mi distanță
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
În curs de recrutareFaza 1
- Virginia Cancer Specialists, Fairfax · La 11 mi distanță
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
În curs de recrutareFaza 3
- Virginia Cancer Specialists (VCS) ( Site 8012), Fairfax · La 11 mi distanță
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
În curs de recrutareFaza 1/2
- NEXT Oncology, Fairfax · La 11 mi distanță
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
În curs de recrutareFaza 3
- Inova Schar Cancer Institute, Fairfax · La 11 mi distanță
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
În curs de recrutareFaza 2
- Virginia Cancer Specialists, Fairfax · La 11 mi distanță
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
În curs de recrutareFaza 1/2
- Inova Schar Cancer Institute, Fairfax · La 11 mi distanță
- Next Oncology Virginia, Fairfax · La 11 mi distanță
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
În curs de recrutareFaza 1
- Virginia Cancer Specialists, Fairfax · La 11 mi distanță
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
În curs de recrutareFaza 1
- NEXT Oncology, Fairfax · La 11 mi distanță
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
În curs de recrutareFaza 3
- Virginia Cancer Specialists (VCS) ( Site 8011), Fairfax · La 11 mi distanță
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
În curs de recrutareFaza 1
- Inova Schar Cancer Institute, Falls Church · La 4 mi distanță
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
În curs de recrutareFaza 1
- Normunity Investigational Site, Fairfax · La 11 mi distanță
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
În curs de recrutare
- Inova Fairfax Hospital, Falls Church · La 4 mi distanță
- Inova Schar Cancer Institute, Fairfax · La 11 mi distanță
- Inova Fair Oaks Hospital, Fairfax · La 11 mi distanță
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- Clinical Trial Site, Fairfax · La 11 mi distanță
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
În curs de recrutareFaza 1/2
- Virginia Cancer Specialists, Fairfax · La 11 mi distanță
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · La 11 mi distanță
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
În curs de recrutareFaza 1/2
- USOR Virginia Cancer Specialists, Fairfax · La 11 mi distanță
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 1/2
- Virginia Cancer Specialists, Fairfax · La 11 mi distanță
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
În curs de recrutareFaza 1
- NEXT Virginia, Fairfax · La 11 mi distanță
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
În curs de recrutareFaza 2
- 522, Fairfax · La 11 mi distanță
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · La 11 mi distanță
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
În curs de recrutareFaza 1
- NEXT Virginia, Fairfax · La 11 mi distanță
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
În curs de recrutareFaza 1
- Virginia Cancer Specialists, Fairfax · La 11 mi distanță
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
În curs de recrutareFaza 1/2
- NEXT Oncology Virginia, Fairfax · La 11 mi distanță
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- NEXT, Fairfax · La 11 mi distanță
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
În curs de recrutareFaza 3
- Inova Schar Cancer Institute, Fairfax · La 11 mi distanță
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
În curs de recrutareFaza 1
- NEXT Oncology Virginia, Fairfax · La 11 mi distanță
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
În curs de recrutareFaza 1/2
- Virginia Cancer Specialists, Fairfax · La 11 mi distanță
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
În curs de recrutareFaza 1
- Virginia Cancer Specialists, Fairfax · La 11 mi distanță
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
În curs de recrutareFaza 1
- NEXT Oncology, Fairfax · La 11 mi distanță
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
În curs de recrutareFaza 1
- Dren Investigational Site, Fairfax · La 11 mi distanță
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
În curs de recrutareFaza 1
- Next Oncology, Virginia Cancer Specialists, Fairfax · La 11 mi distanță
Studii pentru Cancer ovarian în alte orașe
- Houston, TX89 studii
- New York City, NY69 studii
- Boston, MA61 studii
- Los Angeles, CA50 studii
- Nashville, TN49 studii
- Philadelphia, PA44 studii
- Columbus, OH39 studii
- St. Louis, MO38 studii
- Chicago, IL36 studii
- San Antonio, TX31 studii
- Cleveland, OH30 studii
- Pittsburgh, PA30 studii
Alte studii în Arlington
- Cancer pulmonar cu celule non-pătrate104 studii
- Cancer metastatic53 studii
- Cancer colorectal52 studii
- Cancer (toate tipurile)48 studii
- Cancer de sân47 studii
- Cancer pulmonar41 studii
- Cancer endometrial39 studii
- Cancer pancreatic33 studii
- Carcinom cu celule scuamoase de cap și gât26 studii
- Cancer pulmonar cu celule mici23 studii
- Cancer gastric20 studii
- Cancer de sân triplu negativ20 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.